论文部分内容阅读
目的:分析探讨使用卡介苗预防结核病的临床治疗效果,为以后此类病症提供参考依据。方法:选取2014年8月-2015年8月在某院进行治疗的80名结核病患者,使用随机抽样的方法将患者分为对照组和实验组,每组40名;对照组患者注射生理盐水对患者进行预防;实验组患者在对照组患者的基础上注射卡介苗疫苗对患者进行预防,观察比较两组患者的临床改善情况和并发症的发生情况。结果:实验组患者的临床症状改善情况显著优于对照组患者,实验组患者的并发临床症状也明显少于对照组患者。结论:对结核病患者使用卡介苗进行预防,能延长患者的生存时间,减少死亡率,患者的并发症减少,有利于提高患者的生活质量,促进患者的早日康复。
OBJECTIVE: To analyze and discuss the clinical effect of using BCG to prevent tuberculosis and to provide reference for such diseases in the future. Methods: Eighty patients with tuberculosis who were treated in a hospital from August 2014 to August 2015 were randomly divided into control group and experimental group, with 40 in each group. The patients in control group were injected with saline Patients in the experimental group were injected with BCG vaccine on the basis of the control group to prevent the patients. The clinical improvement and complication of the two groups were observed and compared. Results: The improvement of clinical symptoms in the experimental group was significantly better than that in the control group. The clinical symptoms of the experimental group were also significantly less than those in the control group. Conclusion: The prevention of tuberculosis patients using BCG can prolong the survival time of patients and reduce the mortality rate, reduce the patient’s complications, improve the quality of life of patients and promote the early recovery of patients.